4.4 Review

Regulatory T cells (Treg) in rheumatoid arthritis

期刊

JOINT BONE SPINE
卷 76, 期 1, 页码 10-14

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.jbspin.2008.08.002

关键词

T lymphocytes; Rheumatoid arthritis; Immunomodulation; Cytokines; Cell therapy; Regulatory T lymphocytes

资金

  1. French Society for Rheumatology
  2. Courtins Arthritis Foundation
  3. INSERM
  4. National Research Agency
  5. Abbott
  6. BMS
  7. Roche
  8. Sherring-Plough
  9. Wyeth

向作者/读者索取更多资源

Modulation of the T-cell response depends chiefly on regulatory T cells (Treg), which express CD4 and CD25. Some Treg cells are present naturally, whereas others are induced in response to antigens. The immunomodulating effects of Treg cells are mediated by membrane molecules (e.g., CTLA4, GITR, and OX40) and cytokines. IL-35 seems to be a crucial mediator, although IL-10 and TGF beta are also important. The role for Treg cells in rheumatoid arthritis (RA) has been established in both patients and animal models. Treg function is deficient in RA, whereas Treg counts vary. Treg counts increase in patients who are responding to TNF alpha antagonist therapy. Among current hypotheses, Treg expansion or transfer may hold promise for the treatment of RA. (C) 2008 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据